MX2022004570A - Vacunas contra el virus de la gripe y usos de estas. - Google Patents

Vacunas contra el virus de la gripe y usos de estas.

Info

Publication number
MX2022004570A
MX2022004570A MX2022004570A MX2022004570A MX2022004570A MX 2022004570 A MX2022004570 A MX 2022004570A MX 2022004570 A MX2022004570 A MX 2022004570A MX 2022004570 A MX2022004570 A MX 2022004570A MX 2022004570 A MX2022004570 A MX 2022004570A
Authority
MX
Mexico
Prior art keywords
influenza virus
virus vaccines
influenza
methods
same
Prior art date
Application number
MX2022004570A
Other languages
English (en)
Inventor
Boerries Brandenburg
Johannes Petrus Maria Langedijk
Ferdinand Jacobus Milder
Tina Ritschel
Mandy Antonia Catharina Jongeneelen
Original Assignee
Janssen Vaccines & Prevention Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Vaccines & Prevention Bv filed Critical Janssen Vaccines & Prevention Bv
Publication of MX2022004570A publication Critical patent/MX2022004570A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

En la presente se proporcionan polipéptidos de hemaglutinina de la gripe mutante aislados, métodos para proporcionar polipéptidos de hemaglutinina mutantes aislados, composiciones que los comprenden, vacunas que los comprenden y métodos para su uso, en particular en la detección, prevención y/o tratamiento de la gripe.
MX2022004570A 2019-10-15 2020-10-15 Vacunas contra el virus de la gripe y usos de estas. MX2022004570A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962915186P 2019-10-15 2019-10-15
PCT/EP2020/079017 WO2021074286A2 (en) 2019-10-15 2020-10-15 Influenza virus vaccines and uses thereof

Publications (1)

Publication Number Publication Date
MX2022004570A true MX2022004570A (es) 2022-05-06

Family

ID=72944129

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022004570A MX2022004570A (es) 2019-10-15 2020-10-15 Vacunas contra el virus de la gripe y usos de estas.

Country Status (10)

Country Link
US (1) US20230312654A1 (es)
EP (1) EP4045517A2 (es)
JP (1) JP2022553258A (es)
KR (1) KR20220082042A (es)
CN (1) CN115038713A (es)
AU (1) AU2020367242A1 (es)
BR (1) BR112022007253A2 (es)
CA (1) CA3158145A1 (es)
MX (1) MX2022004570A (es)
WO (1) WO2021074286A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024104947A2 (en) 2022-11-14 2024-05-23 Janssen Vaccines & Prevention B.V. Influenza b virus vaccines and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012312529B2 (en) * 2011-09-20 2018-01-04 Icahn School Of Medicine At Mount Sinai Influenza virus vaccines and uses thereof
EA033386B1 (ru) * 2011-11-28 2019-10-31 Janssen Vaccines & Prevention Bv Рекомбинантные иммуногенные полипептиды стеблевого домена гемагглютинина вируса гриппа а и их применение
LT3743106T (lt) * 2018-01-23 2022-09-26 Janssen Vaccines & Prevention B.V. Gripo viruso vakcinos ir jų panaudojimo būdai

Also Published As

Publication number Publication date
AU2020367242A1 (en) 2022-04-14
KR20220082042A (ko) 2022-06-16
WO2021074286A3 (en) 2021-06-24
CN115038713A (zh) 2022-09-09
CA3158145A1 (en) 2021-04-22
JP2022553258A (ja) 2022-12-22
BR112022007253A2 (pt) 2022-07-05
US20230312654A1 (en) 2023-10-05
WO2021074286A2 (en) 2021-04-22
EP4045517A2 (en) 2022-08-24

Similar Documents

Publication Publication Date Title
AU2015286723B2 (en) Influenza virus vaccines and uses thereof
AU2015286721B2 (en) Influenza virus vaccines and uses thereof
EP4233898A3 (en) Influenza mrna vaccines
MX2020001187A (es) Composiciones y métodos para la administración de virus adenoasociados.
PH12016501873A1 (en) Anti-influenza b virus hemagglutinin antibodies and methods of use
MX2016012574A (es) Compuestos heteroarilo sustituidos y metodos de uso.
PH12020500569A1 (en) Influenza virus vaccines and uses thereof
PH12017500450A1 (en) Flavivirus virus like particle
MY189495A (en) Hand, foot, and mouth vaccines and methods of manufacture and use thereof
EP3560950A4 (en) NOVEL MUTANT OF ALFA-CONOTOXIN-PEPTIDE-TXID, PHARMACEUTICAL COMPOSITION AND USE OF IT
MY183072A (en) Methods and compositions for inducing protective immunity against filovirus infection
MX2021009105A (es) Toxinas apxia, apxiia y apxiiia inactivadas.
MX2018006416A (es) Metodos para el tratamiento, prevencion y diagnostico de infeccion por el virus de la diarrea epidemica porcina.
MX2018014955A (es) Vacunas atenuadas vivas del virus de la influenza equina.
MX2021002909A (es) Vacunas de proteinas de fusion neumococicas.
MX2022004570A (es) Vacunas contra el virus de la gripe y usos de estas.
MX2018000023A (es) Particulas semejantes a virus recombinantes que utilizan la proteina gag del virus de inmunodeficiencia bovina.
MX2022002766A (es) Vacunas contra el virus de la gripe y usos de las mismas.
MX2022006312A (es) Inhibidores del receptor de hidrocarburos de arilo (ahr) y usos de los mismos.
PH12020551618A1 (en) Erenumab compositions and uses thereof
MY189021A (en) Peptides and uses therefor as antiviral agents
MA40642A (fr) Nouveaux dérivés peptidiques et leurs utilisations
SG10201900879PA (en) Cdca1-derived peptide and vaccine containing same
WO2017203436A3 (en) Hanta virus gc fragments inhibiting the fusion of the virus with a cell
ZA201700164B (en) Influenza virus vaccines and uses thereof